You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
塞力醫療(603716.SH):控股股東正籌備通過協議轉讓方式減持公司股份事項
格隆匯 01-10 19:16

格隆匯1月10日丨塞力醫療(603716.SH)公佈股票交易異常波動公吿,公司股票交易連續3個交易日(2022年1月6日、1月7日、1月10日)內收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形。

經公司自查,並向控股股東賽海(上海)健康科技有限公司(“賽海科技”)及實際控制人温偉發函核實,賽海科技出於引進戰略投資者、改善公司治理結構等考慮,正在籌備通過協議轉讓方式減持公司股份事項,目前仍處於洽談階段,相關事項仍存在較大不確定性。除此之外,控股股東及實際控制人不存在應披露而未披露的重大信息。

公司目前生產經營活動一切正常,市場環境、行業政策沒有發生重大調整、公司下屬各項業務正常開展,內部生產經營秩序正常。

公吿稱,在國家醫改持續深化的背景下,醫療機構將進入以成本控制為核心的精細化運營時代,在此趨勢下,公司也積極推動服務創新,致力於為醫療機構提供SPD+CDSS(臨牀輔助決策系統)+DRGs/DIP醫保控費服務為一體的智慧醫院精益化管理服務方案。但是,業務轉型尚需投入與發展週期,SPD業務整體尚處於建設階段,現階段整體毛利率10%左右,低於原IVD業務毛利率水平,存在導致公司整體毛利率下滑的風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account